Alector ^Investors

Alector is an innovative angel investment group based in San Francisco, California, founded in 2013 The organization focuses on advancing biotechnology and therapeutic solutions to address neurodegenerative diseases With a significant investment scale of $176,000,000, Alector is dedicated to supporting early-stage companies that demonstrate potential for impactful breakthroughs in healthcare The group combines expertise in science and business to foster the development of transformative therapies Alectors commitment to innovation positions it as a key player in the biotechnology investment landscape